
Celtarys Research
▷ Celtarys | Innovative chemistry to Illuminate Biology.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
€650k | Seed | ||
Total Funding | 000k |
EUR | 2023 | 2024 |
---|---|---|
Revenues | 0000 | 0000 |
% growth | - | (56 %) |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
% profit margin | (5 %) | (291 %) |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
Celtarys is a startup that operates in the pharmaceutical and biotech sectors, specializing in the development and commercialization of innovative fluorescent chemical tools. These tools are designed to enhance the process of drug discovery, making it more efficient and cost-effective. The company's primary clients are other pharmaceutical and biotech companies looking to accelerate their drug discovery projects and increase their competitiveness in the market.
Celtarys' business model revolves around the creation of new chemical tools that utilize fluorescence-based methods. These tools, known as fluorescent ligands, are designed to be potent, selective, and versatile, with a variety of photo-physical properties that meet market demand for various applications. The company's proprietary technology allows for the development of "tailor-suited" fluorescent ligands for each druggable target, enabling a quick and efficient development process.
One of the key selling points of Celtarys' fluorescent ligands is their environmental friendliness. The company uses flexible and convergent synthetic chemical methodologies that are respectful to the environment. This not only aligns with growing consumer demand for eco-friendly products but also helps to reduce costs.
Celtarys also collaborates with several academic research groups and companies expert in drug discovery research. This allows the company to stay at the forefront of the industry and continuously identify opportunities for improvement in drug discovery.
In terms of revenue, Celtarys makes money by selling its fluorescent ligands to pharmaceutical and biotech companies. The company also likely generates income through its collaborations with academic research groups and other companies in the drug discovery field.
Keywords: Drug Discovery, Fluorescent Chemical Tools, Pharmaceutical, Biotech, Collaboration, Environmentally Friendly, Cost-Effective, Innovative, Ligands, Tailor-Suited.